Destiny Pharma appoints Dr Yuri Martina as CMO

Destiny Pharma strengthens Executive Management Team with the appointment oDr Yuri Martina as Chief Medical Officer

Brighton, United Kingdom – 3rd May 2022 – Destiny Pharma plc (AIM:DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections, today announces the appointment of Dr. Yuri Martina as Chief Medical Officer (CMO).

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH